Antibiotics By Diagnosis (Peds)
Bugs & Drugs
Neonatal Infections
NOTE: All doses listed below are for patients >2 kg and at least 7 days of age
Any infant who has tachycardia out of proportion to fever or HR >180 in any age group has a serious bacterial infection (SBI) until proven otherwise. Other serious risk factors include lethargy, hyperventiliation, cyanosis, poor perfusion and hypotonia. Have a high suspicion and treat accordingly. Always treat for meningitis until you are sure it is not. Note that bacterial etiology and antimicrobial therapies are similar for all neonatal illnesses.
| Fever of Uncertain Source (FUS) |
Neonatal (0-30 days): GBS, E. coli, Klebsiella, Enterobacter, Listeria or S. aureus (rare) |
Send blood, urine and CSF cultures. Listeria, while infrequent at CCHMC, may sporadically occur in clustered cases.
|
| Neonatal (30-60 days): See above. |
Workup: Blood and urine specimen. If low-risk (non-ill appearing), normal blood and urine analyses, parents and PMD okay, consider no LP, no antibiotics, and discharge home with f/u in 12-24 hours. Otherwise, LP + Abx.
| |
| Meningitis |
Preterm to 60 days: GBS (49%), E. coli (18%), Listeria (7%), misc GN's, GP's |
If GBS meningitis, treat 21 days. If GN meningitis, treat 21 days (and >14 days after CSF sterilizes). Tailor therapy when specific etiology known |
| Neonatal HSV |
HSV type 1 or 2 |
Risk greatest under 3 weeks of age. Greatest risk factors is primary maternal HSV at delivery. Conjunctival disease may be manifestation of SEM disease.
|
| Pneumonia |
GBS, Listeria, coliforms, S. aureus, Pseudomonas. If AF pneumonitis: Chlamydia, syphilis. Viruses: CMV, HSV, rubella. |
|
| Osteomyelitis |
Newborn period: S. aureus, GN-bacilli, GBS, Gonococcus |
Often afebrile, best predictor is localizing signs. 2/3 have positive blood cultures. Surgical drainage imperative. Seek etiologic diagnosis and tailor therapy. Empirix treatment: Nafcillin 200 mg/kg/day IV div Q6 AND Cefotaxime 150 mg/kg/day IV div Q8 for >21 days. Send joint fluid for cultures and treat based on etiology identified. |
| UTI |
GBS, GN-rods, Listeria, S. aureus |
Pursue imagain as outlined in CCHMC guidelines: www.cincinnatichildrens.org/guidelines. <2 weeks: Ampicillin 100 mg/kg/day IV div Q6 (or Q12 if <7 days) AND Gentamicin 3 mg/kg/day IV Q24 OR Cefotaxime 150 mg/kg/day IV div Q8 2 weeks - 2 months: Ampicillin 100 mg/kg/day IV div Q6 AND Cefotaxime 150 mg/kg/day div Q8 |
| Neonatal conjunctivits |
Neonatal: Determine cause and treatment by number of post-delivery days to onset. Prophylaxis is Erythromycin 0.5% ointment x1 or Tetracycline 1% or Silver Nitrate 1% x1 topical, applied at birth. | |
| Onset 2-4 days: N. gonorrheae |
Hyperpurulent. Topical treatment insufficient. Evaluate for Chlamydia. Treat mother and partners.
| |
| Onset 3-10 days: C. trachomatis |
| |
| Onset 6-14 days: HSV |
Consider if serous discharge (not mucopurulent), bulbar injection and corneal dendrites on fluorescein exam. Consult ophtho immediately! | |
Febrile Syndromes/Bloodstreatm Infections
| Fever of Uncertain Source (FUS) | Infant & Child (2-36 months) |
Workup: If well-appearing, and parents, MD and PMD confortable with follow up, consider no testing. If in season, consider testing for RSV, enterovirus or influenza. Urine: UTI most common serious bacterial infection in males (uncircumcised or <6 months) or females <2 years. Other risk factors include Tmax >39 or Caucasian race. Blood: CBC and blood culture only if ill-appearing or at 'high-risk' for serious bacterial infection. |
| Septic shock syndromes | Bacteremic: S. pneumo, N. meningitidis, Hib (if not immunized) | Replete intravascular volume, maximize delivery of oxygen to tissues. Blood cultures. Ceftriaxone 50 mg/kg/day IV/IM Q24 or Cefotaxime 150 mg/kg/day IV div Q8 until afebrile x24 hours. |
| Toxic shock syndromes: Staphylococcal (less often associated with deep tissue disease), Streptococcal |
Empiric therapy should include Clindamycin and ß-lactam antibiotic until etiology is isolated. Staphylococcal: Most often associated with toxin-producing organism at a mucosal site, may involved disease at a deeper site. Associated with tampon use, wound infection or burns. 5-15% case fatality rate. Rx: Nafcillin AND clindamycin as initial therapy. Can also use Cefazolin or Vancomycin in place of Nafcillin if MRSA suspected. IVIG 1 g/kg may bind toxins, but should be reserved for life-threatening infections. Streptococcal: f GAS, hypotension, renal impairment, coagulopathy, ARDS and soft tissue necrosis. Associated with erisypelas, necrotizing fascitis, secondary infection of varicella. Rx: Once streptococcus is identified, change therapy to Pencillin or other ß-lactam antibiotic PLUS Clindamycin. | |
| Central line infection | Coagulase-negative Staph (CONS), S. aureus, GN-bacilli, Candida spp. |
Coagular-negative Staph (CONS): can try to salvage catheter with 10-14 days of therapy (Vancomycin), 80% cure rate for exit site infections, 25% if deeper. If S. aureus, GN-bacilli or Candida: always remove the catheter if possible. S. aureus has a 10% exit site cure rate and 0% deeper infection cure rate if catheter left in. If septic thrombophlebitis, endocarditis, osteomyelitis or repeated positive cultures, ALWAYS remove catheter. |
| TPN/Intralipids: as above and Malassezia furfur | Remove catheter and discontinue antimicrobials if possible. If Candida albicans, treat with Fluconazole 6-12 mg/kg/day IV Q24 (if >14 days old) x 28 days OR conventional Amphotericin B 1 mg/kg/day IV div Q24. If Staph epi, treat with Vancomycin and discontinue intralipids. If M. furfur, treat with conventional Amphotericin B. | |
Bugs and Drugs Page 10 real.png
Source
Cincinnati Children's Hospital "The Pocket" 2010-2011
